| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.87 | 0.0003 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.0003 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |